Bill Text: NY S01872 | 2023-2024 | General Assembly | Amended
Bill Title: Requires homeless shelters to keep an opioid antagonist on hand at all times and trained personnel when required by when applicable law, regulation, code, or operating plan approved by a social services district or the commissioner otherwise requires employees to be at the premises, sets out the requirements for the training of those employees; develops a training plan for opioid overdoses in conjunction with a registered opioid overdose prevention program.
Spectrum: Slight Partisan Bill (Democrat 3-1)
Status: (Introduced) 2024-05-20 - PRINT NUMBER 1872A [S01872 Detail]
Download: New_York-2023-S01872-Amended.html
STATE OF NEW YORK ________________________________________________________________________ 1872--A 2023-2024 Regular Sessions IN SENATE January 17, 2023 ___________ Introduced by Sens. CLEARE, COMRIE, FERNANDEZ, WEIK -- read twice and ordered printed, and when printed to be committed to the Committee on Social Services -- recommitted to the Committee on Social Services in accordance with Senate Rule 6, sec. 8 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said commit- tee AN ACT to amend the social services law, in relation to requiring home- less shelters to keep an opioid antagonist on hand, have at least one trained employee on duty at all times, and provide an opioid antag- onist training program for residents The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Article 2-A of the social services law is amended by adding 2 a new title 3 to read as follows: 3 TITLE 3 4 OPIOID ANTAGONISTS IN HOMELESS SHELTERS 5 Section 47. Opioid antagonist use and training. 6 § 47. Opioid antagonist use and training. 1. Any provider of temporary 7 housing assistance, which shall include, but not be limited to, a family 8 shelter, a shelter for adults, a hotel, an emergency apartment, a domes- 9 tic violence shelter, a runaway and homeless youth shelter, or a safe 10 house for refugees operating in this state shall have at its premises: 11 (a) an opioid antagonist and a method of administering it on site at 12 all times which may include, but not be limited to, a naloxone kit; and 13 (b) at a minimum, one employee trained in the administration of an 14 opioid antagonist on duty at all times when applicable law, regulation, 15 code, or operating plan approved by a social services district or the 16 commissioner otherwise requires employees to be at the premises. 17 2. All employees of providers of temporary housing assistance who are 18 authorized to administer an opioid antagonist shall: EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD00670-03-4S. 1872--A 2 1 (a) have completed an initial training program, which may include a 2 department of health registered opioid overdose prevention training 3 program; 4 (b) complete a refresher training program at least every two years; 5 (c) contact the emergency medical system during any response to a 6 victim of suspected drug overdose and advise if an opioid antagonist is 7 being used; 8 (d) comply with protocols for response to victims of suspected drug 9 overdose; and 10 (e) report all responses to victims of suspected drug overdose to the 11 department of health. 12 3. All providers of temporary housing assistance shall develop a 13 training plan in conjunction with a registered opioid overdose 14 prevention program in the applicable region regarding the administration 15 of opioid antagonists to any individual residing on a provider's prem- 16 ises who is at risk of experiencing or witnessing an opioid overdose. 17 4. For the purposes of this subdivision, the term "opioid antagonist" 18 shall mean a federal food and drug administration-approved drug that, 19 when administered, negates or neutralizes in whole or in part the phar- 20 macological effects of an opioid in the body and that is limited to 21 naloxone or other medications approved by the department of health for 22 this purpose and "naloxone kit" shall mean a prefilled naloxone syringe 23 or needle-free intranasal drug delivery device. 24 5. The commissioner is authorized to promulgate rules and regulations 25 necessary for the implementation of this title. 26 § 2. This act shall take effect on the thirtieth day after it shall 27 have become a law. Effective immediately, the addition, amendment and/or 28 repeal of any rule or regulation necessary for the implementation of 29 this act on its effective date are authorized to be made and completed 30 on or before such effective date.